High-quality products
Reliable performance
In Vivo Pharmacodynamic Evaluation of B-luc Hep 3B plus Cells Induced Liver Cancer Models (CAT#: STEM-AE-0655-LGZ)
Introduction
Cancer type: Liver cancer
Cell line: B-luc Hep 3B plus
Clone: Single clone
Inoculation: Orthotopic
Principle
By seeding tumor cells at organ-specific sites of the original tumor, in situ models simulate the initial lesion and establish better tumor, stroma, and immune component interactions than subcutaneous implants.
Applications
Liver Cancer
Procedure
1. Disease model construction.
2. Mice dosing.
3. Efficacy monitoring.
4. Biochemical detection of tissue samples.
2. Mice dosing.
3. Efficacy monitoring.
4. Biochemical detection of tissue samples.
Materials
• Sample Type: liquid or powder
Other recommended products
-
In Vivo Pharmacodynamic Evaluation of B-hNCR3 Mice (Immune Checkpoint Humanized Mice) (CAT#: STEM-AE-0361-LGZ)
-
In Vivo Pharmacodynamic Evaluation of HCC38 Cell Line Based Breast Cancer (CAT#: STEM-AE-0018-LGZ)
-
In Vivo Pharmacodynamic Evaluation of B-hNECTIN4 Mice (Humanized Mice) (CAT#: STEM-AE-0637-LGZ)
-
In Vivo Pharmacodynamic Evaluation of B-hHLA-E MC38 plus Cells Induced Tumor Models (CAT#: STEM-AE-0172-LGZ)
-
In Vivo Pharmacodynamic Evaluation of B-hCD79A Mice (Humanized Mice) (CAT#: STEM-AE-0595-LGZ)
-
In Vivo Pharmacodynamic Evaluation of B-hCTLA4/hTIM3 Mice (Immune Checkpoint Humanized Mice) (CAT#: STEM-AE-0387-LGZ)
-
In Vivo Pharmacodynamic Evaluation of B-hSELP Mice (Immune Checkpoint Humanized Mice) (CAT#: STEM-AE-0307-LGZ)
-
In Vivo Pharmacodynamic Evaluation of B-hCD163 Mice (Humanized Mice) (CAT#: STEM-AE-0623-LGZ)
Wide range of applications
For various laboratory needs
Expert support
Professional service team
Fast delivery
Global shipping